Spinal cord lipomas are a common cause of cord tethering that can lead to progressive neurological defects. The role of prophylactic surgery for spinal lipomas has recently been questioned. Between 1985 and 1999, 59 children underwent a total of 69 surgical procedures at the Birmingham Children’s Hospital in Birmingham, UK. The spinal lipomas were classified into: 18 terminal, 17 transitional, 6 dorsal and 18 filum lipomas – including 12 who had a typical thickened filum terminale. At the first operation, 19 patients (32%) were asymptomatic, and 40 patients (68%) presented with symptoms. Surgical indications in the asymptomatic group included the presence of a dermal sinus tract or syrinx. Prophylactic surgery was undertaken in selected cases. The mean total follow-up for the group since the first surgical procedure was 61.8 months (range: 7.0–203.0 months). In the asymptomatic group, 26% of the patients had late neurological deterioration. Of the 14 patients with asymptomatic conus lipomas, 3 (21%) developed sphincter dysfunction and motor problems at long-term follow-up. In the symptomatic group, 68% improved, 20% remained unchanged, and 12% had late neurological deterioration. None of the 18 patients with symptomatic filum lipoma deteriorated postoperatively. However, 39% had bladder dysfunction, 54% had neuro-orthopaedic deformity, and only 15% returned to overall normal function at latest follow-up. Of the 27 patients with symptomatic conus lipomas, 67% improved, 15% remained stable, and 18% had late neurological deterioration. However, 74% had bladder dysfunction, 67% had neuro-orthopaedic deformity, and 45% had motor problems at long-term follow-up. Spinal lipomas can cause progressive neurological deficits irrespective of spinal untethering surgery. This study demonstrates that filum and conus lipomas have similar clinical presentation, but differ in their outcome following surgery. Filum lipomas are ‘benign’, for which surgery is safe and effective. Conus lipomas are more difficult to manage. When asymptomatic, our results suggest that prophylactic surgery does provide some protection from future neurological deterioration. When symptomatic, conus lipoma surgery is effective in stopping further deterioration. Improvement in neurological function can occur, but few patients return to normal overall function, and pre-existing sphincter dysfunction is not significantly altered by surgery.

Keywords:
Spinal lipoma, Lipomyelomeningocele, Occult spinal dysraphism, Tethered cord, Thickened filumterminale, Syringomyelia
1.
Bruce DA, Schut L: Spinal lipomas in infancy and childhood. Childs Brain 1979;5:192–203.
2.
Chapman PH, Frim DM: Symptomatic syringomyelia following surgery to treat retethering of lipomyelomeningoceles. J Neurosurg 1995;82:752–755.
3.
Choux M, Lena G, Genitori L, Foroutan M: The Surgery of Occult Spinal Dysraphism (Advances and Technical Standards in Neurosurgery). Vienna, Springer, 1994, vol 21, pp 183–238.
4.
Hoffman HJ, Taecholarn C, Hendrick EB, Humphreys RP: Management of lipomyelomeningoceles. J Neurosurg 1985;62:1–8.
5.
Kanev PM, Bierbrauer KS: Reflections on the Natural History of Lipomyelomeningocele. Pediatr Neurosurg 1995;22:137–140.
6.
Kanev PM, Lemire RJ, Loeser JD, Berger MS: Management and long-term follow-up review of children with lipomyelomeningocele, 1952–1987. J Neurosurg 1990;73:48–52.
7.
La Marca F, Grant JA, Tomita T, McLone DG: Spinal lipomas in children: Outcome of 270 procedures. Pediatr Neurosurg 1997;26:8–16.
8.
Lapras C, Patet JD, Huppert J, Mottolese C: The tethered cord syndrome (experience of 58 cases). J Pediatr Neurosci 1985;1:39–50.
9.
Pierre-Kahn A, Zerah M, Renier D, Cinalli G, Sainte-Rose C, Lellouch-Tubiana A, Brunelle F, Le Merrer M, Giudicelli Y, Pichon J, Kleinknecht B, Nataf F: Congenital lumbosacral lipomas. Childs Nerv Syst 1997;13:298–334.
10.
McLone DG, Naidich TP: Laser resection of fifty spinal lipomas. Neurosurgery 1986;18:611–615.
11.
Pierre-Kahn A, Lacombe J, Pichon J, Giudicelli Y, Renier D, Sainte-Rose C, Perrigot M, Hirsch JF: Intraspinal lipomas with spina bifida: Prognosis and treatment in 73 cases. J Neurosurg 1986;65:756–761.
12.
Schut L, Bruce DA, Sutton LN: The management of the child with lipomyelomeningocele. Clin Neurosurg 1983;30:446–476.
13.
Cornette L, Verpoorten C, Lagae L, Van Calenbergh F, Plets C, Vereecken R, Casaer P: Tethered cord syndrome in occult spinal dysraphism. Neurology 1998;50:1761–1765.
14.
Liptak GS: Tethered spinal cord: Update of an analysis of published articles. Eur J Pediatr Surg 1995;5:21–23.
15.
Van Calenbergh F, Vanvolsem S, Verpoorten C, Lagae L, Casaer P, Plets C: Results after surgery for lumbosacral lipoma: The significance of early and late worsening. Childs Nerv Syst 1999;15:439–443.
16.
Byrne RW, Hayes EA, George TM, McLone DG: Operative resection of 100 spinal lipomas in infants less than 1 year of age. Pediatr Neurosurg 1995;23:182–187.
17.
Herman JM, McLone DG, Storrs BB, Dauser RC: Analysis of 153 patients with myelomeningocele or spinal lipoma reoperated upon for a tethered cord. Pediatr Neurosurg 1993;19:243–249.
18.
Koyanagi I, Iwasaki Y, Hida K, Abe H, Isu T, Akino M: Surgical treatment supposed natural history of the tethered cord with occult spinal dysraphism. Childs Nerv Syst 1997;13:268–274.
19.
Chapman PH, Beyerl B: The tethered spinal cord with particular reference to spinal lipoma and diastematomyelia; in Hoffman HJ, Epstein F (eds): Disorders of the Developing Nervous System. Diagnosis and Treatment. Boston, Blackwell, 1986, pp 109–132.
20.
Chapman PH, Davis KR: Surgical treatment of spinal lipomas in childhood. Concepts Paediatr Neurosurg 1983;3:178–190.
21.
Chapman PH: Congenital intraspinal lipomas. Anatomic considerations and surgical treatment. Childs Brain 1979;9:37–47.
22.
Albright AL, Gartner JC, Wiener ES: Lumbar cutaneous haemangiomas as indicators of tethered spinal cord. Paediatrics 1989;83:977–980.
23.
Souweidane MM, Drake JM: Retethering of sectioned fibrolipomatous filum terminales: Report of two cases. Neurosurgery 1998;42:1390–1393.
24.
Uchino A, Ohno M: Thickened fatty filum terminale: MR imaging. Neuroradiology 1991;33:331–333.
25.
Yundt KD, Park TS, Kaufman BA: Normal diameter of filum terminale in children: In vivo measurement. Pediatr Neurosurg 1997;27:257–259.
26.
Hoffman HJ, Hendrick EB, Humphreys RP: The tethered spinal cord: Its protean manifestations, diagnosis and surgical correction. Childs Brain 1976;2:145–155.
27.
Brunberg JA, Latchaw RE, Kanal E, Burk L, Albright L: Magnetic resonance imaging of spinal dysraphism. Radiol Clin North Am 1988;26:181–205.
28.
Hakuba A, Fujitani K, Hoda K: Lumbosacral lipoma, the timing of operation and morphological classification. Neuroorthopedics 1986;2:34–42.
29.
McLone DG, Naidich TP: Terminal myelocystocele. Neurosurgery 1985;16:34–43.
30.
Sato K, Shimoji T, Sumie H, Yaguchi K, Kuru Y, Ishii S: Surgically confirmed myelographic classification of congenital intraspinal lipoma in the lumbosacral region. Childs Nerv Syst 1985;1:3–11.
31.
Scatliff JH, Kendall BE, Kingsley DPE, Britton J, Grant DN, Hayward RD: Closed spinal dysraphism: Analysis of clinical, radiological, and surgical findings in 104 consecutive patients. AJR 1989;152:1049–1057.
32.
McLone DG, Naidich TP: The tethered spinal cord; in McLaurin RL, Schut L, Venes JL, Epstein F (eds): Paediatric Neurosurgery, ed 2. Philadelphia, Saunders, 1989, pp 71–96.
33.
French BN: The embryology of spinal dysraphism. Clin Neurosurg 1982;30:295–340.
34.
Pierre-Kahn A, Zerah M, Renier D: Lipomes malformatifs intrarachidiens. Neurochirurgie 1995;41:1–134.
35.
Brown E, Matthes JC, Bazan C, Jinkins JR: Prevalence of incidental intraspinal lipoma of the lumbosacral spine as determined by MRI. Spine 1994;19:833–836.
36.
McLendon RE, Oakes WJ, Heinz ER, Yeates AE, Burger PC: Adipose tissue in the filum terminale: A computed tomographic finding that may indicate tethering of the spinal cord. Neurosurgery 1988;22:873–876.
37.
Modic MT, Masaryk TJ, Ross JS: Magnetic resonance imaging of the spine. Chicago, Yearbook Medical Publishers, 1989, pp 20–34.
38.
Iskandar BJ, Oakes WJ, McLaughlin C, Osumi AK, Tien RD: Terminal syringohydromyelia and occult spinal dysraphism. J Neurosurg 1994;81:513–519.
39.
Sarwark JF, Weber DT, Gabrieli AP, McLone DG, Dias L: Tethered cord syndrome in low motor level children with myelomeningocele. Pediatr Neurosurg 1996;25:295–301.
40.
Yamada S, Zinke DE, Sanders D: Pathophysiology of ‘tethered cord syndrome’. J Neurosurg 1981;54:494–503.
41.
Naidich TP, McLone DG, Mutluer S: A new understanding of dorsal dysraphism with lipoma (lipomyeloschisis): Radiological evaluation and surgical correction. AJNR 1983;4:103–116.
42.
Lhowe D, Ehrlich MG, Chapman PH, Zaleske DJ: Congenital intraspinal lipomas. Clinical presentation and response to treatment. J Paediatr Orthop 1987;7:531–537.
43.
Harris HW, Miller OF: Midline cutaneous and spinal defects. Midline cutaneous abnormalities associated with occult spine disorders. Arch Dermatol 1976;112:1724–1728.
44.
Serna MJ, Vasquez-Doval J, Vanaclocha V, Zubieta JL, Quintanilla E: Occult spinal dysraphism: A neurosurgical problem with a dermatological hallmark. Paediatr Dermatol 1993;10:149–152.
45.
Oi S, Matsumoto S: A proposed grading and scoring system for spina bifida: Spina bifida neurological scale (SBNS). Childs Nerv Syst 1992;8:337–342.
46.
Chapman PH, Davis KR: Surgical treatment of spinal lipomas in childhood. Pediatr Neurosurg 1993;19:267–275.
47.
Mircevski M, Mircevska I, Bojadziev R, Basevska R: Surgical treatment of spinal lipomas in infancy and childhood. Childs Brain 1983;10:317–332.
48.
Lagae L, Verpoorten C, Casaer P, Vereecken R, Fabry G, Plets C: Conservative versus neurosurgical treatment of tethered cord patients. Z Kinderchir 1990;45(suppl 1):16–17.
49.
Raimondi AJ: Hamartomas and the dysraphic state; in Raimondi AJ (ed): Paediatric Neurosurgery. Theoretical Principles, Art of Surgical Techniques Berlin, Springer, 1987, pp 423–452.
50.
Pang D, Wilberger JE Jr: Tethered cord syndrome in adults. J Neurosurg 1982;57:32–47.
51.
Loeser JD, Lewin RJ: Lumbosacral lipoma in the adult. Case report. J Neurosurg 1968;29:405–409.
52.
Mauri F, Gambarella A, Trinchillo G: Congenital lumbosacral lesions with late onset in adult life. Neurol Res 1989;11:328–344.
53.
Sharif S, Allcutt D, Marks C, Brennan P: Tethered cord syndrome – Recent clinical experience. Br J Neurosurg 1997;11:49–51.
54.
Sathi S, Madsen JR, Bauer S, Scott RM: Effects of surgical repair on the neurourological function in infants with lipomeningocele. Pediatr Neurosurg 1993;19:256–259.
55.
Stolke D, Zumkeller M, Seifert V: Intraspinal lipomas in infancy and childhood causing a tethered cord syndrome. Neurosurg Rev 1988;11:59–65.
56.
Colak A, Pollack IF, Albright AL: Recurrent tethering: A common long-term problem after lipomyelomeningocele repair. Pediatr Neurosurg 1998;29:184–190.
57.
Zide B, Constantini S, Epstein FJ: Prevention of recurrent tethered spinal cord. Pediatr Neurosurg 1995;22:111–114.
58.
Harrison MJ, Mitnick MJ, Rosenblum BR, Rothman AS: Leptomyelolipoma: Analysis of 20 cases. J Neurosurg 1990;73:360–367.
59.
Shinomiya K, Fuchioka M, Matsuoka T, Okamoto A, Yoshida H, Mutoh N, Furuya K, Andoh M: Intraoperative monitoring for tethered spinal cord syndrome. Spine 1991;16:1290–1294.
60.
Sakamoto H, Hakuba A, Fujitani K, Nishimura S: Surgical treatment of the retethered spinal cord after repair of lipomyelomeningocele. J Neurosurg 1991;74:709–714.
61.
Selcuki M, Coskun K: Management of tight filum terminale syndrome with special emphasis on normal level conus medullaris. Surg Neurol 1998;50:318–322.
62.
Koyanagi I, Iwasaki Y, Hida K, Abe H, Isu T, Akino M: Surgical treatment of syringomyelia associated with spinal dysraphism. Childs Nerv Syst 1997;13:194–200.
63.
Aoki N: Syringomyelia secondary to congenital intraspinal lipoma. Surg Neurol 1991;35:360–365.
64.
Gupta RK, Sharma A, Jena A, Tyagi G, Prakash B, Khushu S: Magnetic resonance evaluation of spinal dysraphism in children. Childs Nerv Syst 1990;6:161–165.
© 2000 S. Karger AG, Basel
2000
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.